🚀Do it way faster! 🚀 Tired of the tedious grind of manual literature screening? Watch how our DrugCard platform transforms hours of work into minutes, boosting efficiency and accuracy for PV specialists. Ready to supercharge your pharmacovigilance processes? Click play and see the future in action! 🔍 💼 #pharmacovigilance #drugsafety #literaturemonitoring #PV
DrugCards
Pharmaceutical Manufacturing
Tallinn, --- 8,221 followers
DrugCard is a SaaS for automated medical literature monitoring.
About us
DrugCard provides a cost-effective full-regulatory compliant software designed for the drug safety departments to automate medical literature monitoring
- Website
-
https://drug-card.io
External link for DrugCards
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Tallinn, ---
- Type
- Privately Held
- Founded
- 2021
- Specialties
- pharmacovigilance, SaaS, drugsafety, drug safety, MLM, local literature, and medical literature monitoring
Products
DrugCard
Pharmacovigilance Software
DrugCard provides full-regulatory compliant SaaS to help pharmacovigilance teams, trimming literature screening time by 70% and generating deeper insights about drug safety using sophisticated parsers and AI-tech Key features: • Automated literature screening with weekly search reports • 950+ local medical journals in 50+ countries • Global literature monitoring via Pubmed • Instant notifications with new drug safety information • GVP, CRF 21 part 11, GAMP5 compliance • Data security SOC type 2/3 and ISO/IEC 27001:2013 • Traceable workflow with user roles • Accessibility 24/7 and customer support To start 14 days trial, feel free to connect: [email protected]
Locations
-
Primary
Ahtri tn 12
Harju maakond, Kesklinna linnaosa
Tallinn, --- 10151, EE
Employees at DrugCards
Updates
-
How does the EU safeguard medicines? 🏥 How do you can practice pharmaceutical safety? 💊 Find answers to these and more in our weekly newsletter. Don't miss out! #pharmacy #drugdevelopment #medical #regulatoryaffairs #pharma #pharmaceuticals
-
𝗦𝗽𝗼𝘁𝘁𝗶𝗻𝗴 𝗥𝗮𝗿𝗲 𝗔𝗗𝗥𝘀: 𝗧𝗵𝗲 𝗥𝗼𝗹𝗲 𝗼𝗳 📚𝗟𝗶𝘁𝗲𝗿𝗮𝘁𝘂𝗿𝗲 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲 Rare adverse drug reactions (ADRs) may be uncommon, but their impact on patient safety is significant. ❗️Literature monitoring is crucial in #pharmacovigilance, helping us detect these elusive cases often hidden in medical publications. 🚀Platforms like 𝘿𝙧𝙪𝙜𝘾𝙖𝙧𝙙 streamline this process by efficiently scanning and analyzing vast literature, enabling quicker identification of rare 💊ADRs. This proactive approach strengthens #patientsafety measures and ensures that therapeutic outcomes are continually optimized. #drugsafety #GVP
-
𝗪𝗵𝘆 𝗥𝗲𝗳𝗲𝗿𝗿𝗮𝗹 𝗣𝗿𝗼𝗰𝗲𝗱𝘂𝗿𝗲𝘀 𝗠𝗮𝘁𝘁𝗲𝗿 𝗶𝗻 𝗗𝗿𝘂𝗴 𝗦𝗮𝗳𝗲𝘁𝘆 Have you ever wondered how the 🇪🇺EU handles drug safety concerns affecting multiple countries? That's where 𝙍𝙚𝙛𝙚𝙧𝙧𝙖𝙡 𝙋𝙧𝙤𝙘𝙚𝙙𝙪𝙧𝙚𝙨 come in! ⚖️Referral procedures are like the safety net of the #pharmaceutical world. When there's a big question or safety issue about a 💊drug, these procedures bring all EU member states together to find a common solution. This ensures that decisions are consistent across Europe, keeping patients safe and building trust in medicines. ☑️Whether you're in #regulatory affairs or #pharmacovigilance, understanding referral procedures is critical to navigating drug safety challenges. 🧠Curious to learn more? Please read our new blog post: https://lnkd.in/gKsjmjt2
-
-
The new #pharmaceuticals data dose is on approach. 💊 Don't miss the weekly portion of the industry updates and facts! #pharmacy #drugdevelopment #medical #regulatoryaffairs #pharma
Data Dose August 2024 #4
DrugCards on LinkedIn
-
🫀𝙃𝙤𝙬 𝘾𝙤𝙢𝙢𝙤𝙣 𝙈𝙚𝙙𝙞𝙘𝙖𝙩𝙞𝙤𝙣𝙨 𝘾𝙖𝙣 𝙏𝙧𝙞𝙜𝙜𝙚𝙧 𝙇𝙞𝙛𝙚-𝙏𝙝𝙧𝙚𝙖𝙩𝙚𝙣𝙞𝙣𝙜 𝙃𝙚𝙖𝙧𝙩 𝙍𝙝𝙮𝙩𝙝𝙢𝙨 Many people don't realize that some widely used 💊medications can trigger a serious heart rhythm disorder called Long QT Syndrome (LQTS). This often-overlooked condition can lead to severe arrhythmias, causing fainting, seizures, or even sudden death. ❗️From antiarrhythmics to antibiotics and antipsychotics, #drugs across various classes can extend the QT interval, disrupting the heart's electrical signals. This disruption can pave the way for torsades de pointes, a rare but deadly form of tachycardia. 🔥For instance, the #DrugCard platform recently uncovered an infrequent case where even short-term use of amiodarone resulted in LQTS and torsades de pointes, highlighting the need for vigilance. #pharmaceutical #drugsafety #Pharmacovigilance
-
🌚𝗡𝗶𝗴𝗵𝘁𝗺𝗮𝗿𝗲𝘀: 𝗔𝗻 𝗨𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻? When we think of drug 💊side effects, common symptoms like nausea or headaches often come to mind. But did you know that some medications can lead to vivid nightmares? While it's not a typical side effect, certain drugs - especially those affecting the central nervous system - have been known to disrupt 😴sleep patterns and trigger intense, unsettling dreams. Antidepressants, beta-blockers, and even some antihistamines have been reported to cause this rare but intriguing phenomenon. 🔥Interestingly, the DrugCard platform recently uncovered a case in the medical literature where Metformin - a common #diabetes medication - was linked to nightmares in a patient. This unexpected side effect highlights the importance of vigilant #pharmacovigilance and the need to consider all possibilities when assessing #patient reactions. 🧠For more details, check out our latest blog post: https://lnkd.in/dMwCRspr
-
-
New Collaboration Alert! We are delighted to announce our partnership with ASPHALION, whose experts have delivered solutions to over 1,000 pharmaceutical, biotechnological, and medical technology companies from more than 50 countries. With a track record of over 5,000 projects covering non-clinical and clinical development, Asphalion brings a wealth of experience and innovation to the table. Their core values of passion, flexibility, commitment, quality, and companionship align perfectly with our vision. Together, we are dedicated to advancing healthcare and improving lives. #Partnership #HealthcareInnovation #Asphalion #DrugCard #CommitmentToExcellence #HealthImprovement
-
-
Stay updated with the latest in #pharma! 💊 🆕 Dive into our weekly newsletter for fresh insights in #pharmaceuticals, #pharmacy, #drugdevelopment, #medical, and #regulatoryaffairs. Make sure you don’t miss out on the crucial highlights!
Data Dose August 2024 #3
DrugCards on LinkedIn